SCHEMBL16367661

SCHEMBL16367661

CC(C)(C)OC(=O)N1CCC(NCc2nc3ccc(O)cc3s2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
DNMT3A Q9Y6K1 1/20 0.42
DYRK1A Q13627 1/20 0.42
ALDH1A1 P00352 2/20 0.42
PIK3CA P42336 1/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
EPHX2 P34913 1/20 0.41
MAOB P27338 3/20 0.41
MAOA P21397 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
ESR2 Q92731 1/20 0.40
KDM1A O60341 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353976 0.82 MAOB (0.65) MAPTMAOBMAOALIPGEPHX1
SCHEMBL4396712 0.79 MAOA (0.64) L3MBTL1DYRK1AALDH1A1NPC1MAPK1
SCHEMBL23290595 0.77 KDM4E (0.43) L3MBTL1DNMT3ADYRK1AALDH1A1NPC1
SCHEMBL8735045 0.77 MAPT (0.54) ALDH1A1NPC1MAPTMAPK1RAB9A
SCHEMBL23290993 0.77 DPP4 (0.41) L3MBTL1DNMT3ADYRK1AALDH1A1NPC1
SCHEMBL21819943 0.76 MAOB (0.47) DYRK1AMAOB
SCHEMBL545073 0.75 DYRK1A (0.49) L3MBTL1DYRK1ANPC1RAB9AMAOB
SCHEMBL13281549 0.75 RAB9A (0.56) PIK3CANPC1MAPTRAB9AGPR119
Bromide SCHEMBL9774868 0.74 SMN1; SMN2 (0.57) L3MBTL1ALDH1A1NPC1MAPTMAPK1
SCHEMBL27712805 0.72 DYRK2 (0.54) L3MBTL1DYRK1AALDH1A1PIK3CANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150011582-A1 Carboxamide Compounds and Methods for Using the Same MIDCAP FINANCIAL TRUST 2015-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011582-A1 Carboxamide Compounds and Methods for Using the Same PC, AK2, PRKAA2 L3MBTL1 2576/4885DNMT3A 2017/4885DYRK1A 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.